Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
AstraZeneca
Daiichi Sankyo
Healthtrust
Julphar

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 4,740,463

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,740,463
Title: Methods and artificial genes for antagonizing the function of an oncogene
Abstract:A method of antagonizing the effects of an oncogene by constructing an artificial gene which antagonizes the function of the oncogene is described herein. In one embodiment, the artificial gene comprises a transcriptional promoter segment, an inverted oncogene segment, and a polyadenylation segment.
Inventor(s): Weinberg; Robert A. (Brookline, MA), Bargmann; Cornelia I. (Athens, GA), Stern; David F. (Cambridge, MA)
Assignee: Massachusetts Institute of Technology (Boston, MA)
Application Number:06/599,936
Patent Claims:see list of patent claims

Details for Patent 4,740,463

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Massachusetts Institute of Technology (Boston, MA) 2037-11-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Massachusetts Institute of Technology (Boston, MA) 2037-11-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Massachusetts Institute of Technology (Boston, MA) 2037-11-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Johnson and Johnson
Daiichi Sankyo
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.